Re: Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only

Eur Urol. 2023 Jun;83(6):582-583. doi: 10.1016/j.eururo.2023.02.022. Epub 2023 Mar 10.

Authors

Alexander P Kenigsberg¹, Michael Ahdoot², Baris Turkbey³, Peter A Pinto⁴

Affiliations

¹ Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: alexander.kenigsberg@nih.gov.
² Department of Urology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
³ Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
⁴ Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

PMID: 36907691
DOI: 10.1016/j.eururo.2023.02.022

No abstract available

MeSH terms

Biopsy
Early Detection of Cancer
Humans
Image-Guided Biopsy
Magnetic Resonance Imaging
Male
Prostate-Specific Antigen
Prostatic Neoplasms* / pathology

Substances

Prostate-Specific Antigen